Found: 19
Select item for more details and to access through your institution.
P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S160, doi. 10.1016/S2152-2650(21)02346-6
- By:
- Publication type:
- Article
P-202: Characterization of ocular adverse events in patients receiving Belantamab Mafadotin for ≥12 months: post-hoc analysis of DREAMM-2 study in relapsed/refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S149, doi. 10.1016/S2152-2650(21)02329-6
- By:
- Publication type:
- Article
MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S419, doi. 10.1016/S2152-2650(21)01940-6
- By:
- Publication type:
- Article
Poster: MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥ 12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01576-7
- By:
- Publication type:
- Article
Update on Dry Eye Disease-Reply.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Dry Eye Disease: An Update in 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
- By:
- Publication type:
- Article
Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
- Published in:
- Ophthalmology & Therapy, 2020, v. 9, n. 4, p. 889, doi. 10.1007/s40123-020-00280-8
- By:
- Publication type:
- Article
The Effect of Pharmacological Dilation on Calculation of Targeted and Ideal IOL Power Using Multivariable Formulas.
- Published in:
- Ophthalmology & Therapy, 2020, v. 9, n. 3, p. 1, doi. 10.1007/s40123-020-00261-x
- By:
- Publication type:
- Article
Surgical Curriculum for Presbyopia-Correcting Intraocular Lenses: Resident Experiences and Surgical Outcomes.
- Published in:
- Clinical Ophthalmology, 2020, v. 14, p. 2441, doi. 10.2147/OPTH.S263249
- By:
- Publication type:
- Article
Scleritis and Retinal Detachment After Strabismus Surgery in a Patient With Thyroid Eye Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Chronic Follicular Conjunctivitis in a Middle-aged Woman.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pediatric Patient With T-Cell Lymphoblastic Lymphoma and Acute Vision Loss.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Conjunctival Lesion in a Patient With Ocular Graft-vs-Host Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Asymptomatic Intraocular Mass.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Subconjunctival Hemorrhages and Retinal Vascular Abnormalities.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 2, p. 217, doi. 10.1001/jamaophthalmol.2014.4847
- By:
- Publication type:
- Article
The microbiome and ophthalmic disease.
- Published in:
- Experimental Biology & Medicine, 2019, v. 244, n. 6, p. 419, doi. 10.1177/1535370218813616
- By:
- Publication type:
- Article
Biomarkers of Pediatric Cataracts: A Proteomics Analysis of Aqueous Fluid.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 9040, doi. 10.3390/ijms24109040
- By:
- Publication type:
- Article